Araki Yoichi, Rajkovich Kacey E, Gerber Elizabeth E, Gamache Timothy R, Johnson Richard C, Tran Thanh Hai N, Liu Bian, Zhu Qianwen, Hong Ingie, Kirkwood Alfredo, Huganir Richard
Department of Neuroscience, Kavli Neuroscience Discovery Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Science. 2024 Mar;383(6686):eadk1291. doi: 10.1126/science.adk1291. Epub 2024 Mar 1.
SynGAP is an abundant synaptic GTPase-activating protein (GAP) critical for synaptic plasticity, learning, memory, and cognition. Mutations in in humans result in intellectual disability, autistic-like behaviors, and epilepsy. Heterozygous -knockout mice display deficits in synaptic plasticity, learning, and memory and exhibit seizures. It is unclear whether SynGAP imparts structural properties at synapses independently of its GAP activity. Here, we report that inactivating mutations within the GAP domain do not inhibit synaptic plasticity or cause behavioral deficits. Instead, SynGAP modulates synaptic strength by physically competing with the AMPA-receptor-TARP excitatory receptor complex in the formation of molecular condensates with synaptic scaffolding proteins. These results have major implications for developing therapeutic treatments for -related neurodevelopmental disorders.
SynGAP是一种丰富的突触GTP酶激活蛋白(GAP),对突触可塑性、学习、记忆和认知至关重要。人类中的突变会导致智力残疾、自闭症样行为和癫痫。杂合子敲除小鼠在突触可塑性、学习和记忆方面表现出缺陷,并出现癫痫发作。目前尚不清楚SynGAP是否独立于其GAP活性在突触处赋予结构特性。在这里,我们报告GAP结构域内的失活突变不会抑制突触可塑性或导致行为缺陷。相反,SynGAP通过在与突触支架蛋白形成分子凝聚物的过程中与AMPA受体-TARP兴奋性受体复合物进行物理竞争来调节突触强度。这些结果对开发与相关神经发育障碍的治疗方法具有重要意义。